SER
Serina Therapeutics Inc
2.00$
-0.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +13.1% | +24.8% | +21.5% | -47.8% | +94.1% | -18.1% | -17.6% | +0.0% | +21.4% | +8.2% | +33.6% | -6.2% | -19.6% | +4.8% | +16.4% | -88.9% | -33.9% | -35.1% | -91.7% | +150.0% | +140.0% | -25.0% | -11.1% | +275.0% | -76.7% | +314.3% | +10,544.8% | -99.8% | +920.0% | -72.5% | -200.0% | – | – | -100.0% | – | – | – | – | |
| – | +2.5% | -34.0% | -0.6% | +35.0% | -13.9% | -21.5% | +119.2% | -80.3% | +382.5% | +0.7% | -3.4% | +35.7% | +0.7% | +4.0% | +46.4% | -94.1% | +27.8% | -26.1% | +0.0% | +0.0% | +14.7% | -2.6% | -10.5% | -61.8% | +38.5% | +194.4% | -88.7% | +316.7% | +128.0% | +4,136.8% | -2.1% | -99.3% | -5.9% | +22,718.8% | -6.8% | -99.5% | – | – | |
| – | +100.0% | +272.4% | +38.0% | -92.3% | +1,108.7% | -15.8% | -103.0% | – | – | +38.2% | +141.4% | -55.0% | -91.2% | +40.0% | -885.7% | – | -145.0% | – | – | – | – | – | – | – | -164.7% | – | – | -100.6% | – | – | – | – | – | -3,302.6% | – | – | – | – | |
| – | -26.2% | +24.9% | -18.4% | +27.8% | -13.9% | -5.3% | +14.4% | -3.3% | +12.9% | -13.4% | +1.8% | +10.0% | -17.2% | -42.3% | +49.6% | -72.2% | +54.0% | -45.8% | +41.2% | +5.8% | -37.7% | -42.9% | +35.7% | +128.0% | +20.1% | +14.8% | +64.9% | +21.9% | +44.1% | +51.5% | -2.1% | +24.8% | +6.8% | +15.8% | -6.8% | -5.9% | +19.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -20.2% | +87.9% | +118.1% | -37.1% | +90.4% | +25.3% | -49.6% | +98.2% | -12.5% | +7.8% | -5.0% | +18.4% | -3.7% | – | |
| – | -26.9% | +1.3% | -13.5% | +49.5% | -13.0% | +1.2% | +37.3% | +2.9% | +2.1% | -3.8% | -12.2% | +11.4% | -20.4% | -8.2% | -3.3% | -1.0% | -5.1% | -24.2% | +11.8% | +8.8% | -22.7% | -2.7% | +15.5% | -44.2% | -4.6% | +54.1% | +97.4% | -19.0% | +68.0% | -24.7% | +8.9% | +84.8% | -3.1% | -51.7% | +2.4% | +123.2% | +8.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,063.1% | – | – | – | – | – | – | – | – | – | – | |
| – | -16.7% | – | – | – | – | – | – | – | – | – | – | +116.7% | +67.3% | +71.3% | +41.6% | +15.2% | +12.8% | +4.0% | +3.5% | +278.0% | -22.6% | +7.0% | +6.0% | -91.2% | +25.6% | -7.4% | +76.0% | -43.8% | +144.4% | -93.4% | +6.3% | -100.0% | – | -33.3% | +3,200.0% | -4.5% | +7.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -51.3% | +116.8% | -40.0% | -1,528.6% | – | -73.3% | -299.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -95.9% | +1,700.0% | -66.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -116.7% | – | -127.3% | – | – | – | – | – | – | -61.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -51.3% | +116.8% | -40.0% | -1,528.6% | – | -72.9% | -294.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -46.9% | +104.2% | -35.3% | -1,300.6% | – | -73.4% | -284.1% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.